Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Concord Drugs Ltd.
Swot
Concord Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Concord Drugs Ltd. has 16 Strengths, 11 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(16)
Weakness
(11)
Opportunity
(0)
Threats
(0)
Others
(6)
Turnaround Potential (DVM)
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Stringent DVM Screener - maximize returns
Weekly Strategy: High Momentum Score Stocks (subscription)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Companies with Zero Promoter Pledge
Stock gained more than 20% in one month
Highest Recovery from 52 Week Low
Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Negative Breakdown Third Support (LTP < S3)
PE higher than Industry PE
High PE (PE > 40)
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Declining Revenue every quarter for the past 2 quarters
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Increasing Trend in Non-Core Income
Top Losers
High Delivery Percentage
Trendlynes high return technically strong value stocks (subscription)
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)
Decline in Quarterly Net Profit with falling Profit Margin (YoY)
